SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-21-015256
Filing Date
2021-04-30
Accepted
2021-04-30 15:37:55
Documents
5
Period of Report
2021-06-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A nc10023533x1_def14a.htm DEF 14A 576759
2 logo_pliant.jpg GRAPHIC 44873
3 logo_pliantx1.jpg GRAPHIC 33501
4 nc10023533x1_pc01.jpg GRAPHIC 467303
5 nc10023533x1_pc02.jpg GRAPHIC 421165
  Complete submission text file 0001140361-21-015256.txt   1908430
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39303 | Film No.: 21877371
SIC: 2834 Pharmaceutical Preparations